Ability of different rescue therapies to save the bowel in acute, severe, steroid-refractory ulcerative colitis

References

• Hoentjen F, Sakuraba A, Hanauer S. Update on management of ulcerative colitis. Curr Gastroenterol Rep 2011;13:475-85
   PubMedGoogle Scholar
• Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330:1841-5
   PubMed Web of Science ®Google Scholar
• Jarnerot G, Hertervig E, Friis-Liby I, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 2005;128:1805-11
   PubMed Web of Science ®Google Scholar
• Moskovitz DN, Van Asche G, Maenhout B, et al. Incidence of colectomy during long term follow-up after cyclosporine induced remission of severe ulcerative colitis. Clin Gastroenterol Hepatol 2006;4:760-5
   PubMed Web of Science ®Google Scholar
• Campbell S, Travis S, Jewell D. Cyclosporine use in acute ulcerative colitis: a long-term experience. Eur J Gastroenterol Hepatol 2005;7:79-84
   Google Scholar
• Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005;353:2462-76
   PubMed Web of Science ®Google Scholar
• D’Haens G, Lemmens L, Geboes K, et al. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology 2001;120:1323-9
   PubMed Web of Science ®Google Scholar
• Van Assche G, D’Haens G, Noman M, et al. Randomized, double blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology 2003;125:1025-31
   PubMed Web of Science ®Google Scholar
• Dignass A, O Lindsay J, Sturm A, et al. Second European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Current management. J Crohn Colitis 2012;6:991-1030
   PubMed Web of Science ®Google Scholar
• Mocciaro F, Renna S, Orlando A, et al. Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational study. J Crohns Colitis 2012;6:681-6
   PubMed Web of Science ®Google Scholar
• Sharkey L, Bredin F, Nightingale A, et al. The use of Cyclosporine A in acute steroid-refractory ulcerative colitis: long term outcomes. J Crohns Colitis 2011;5:91-4
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Naganuma M, Okamoto S, et al. Rapid endoscopic improvement is important for 1-year avoidance of colectomy but not for the long-term prognosis in cyclosporine A treatment for ulcerative colitis. J Gastroenterol 2010;45:1129-37
   PubMed Web of Science ®Google Scholar
• Cheifetz AS, Stern J, Garud S, et al. Cyclosporine is safe and effective in patients with severe ulcerative colitis. J Clin Gastroenterol 2011;45:107-12
   PubMed Web of Science ®Google Scholar
• Sjöberg M, Walch A, Meshkat M, et al. Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study. Inflamm Bowel Dis 2012;18:212-18
   PubMed Web of Science ®Google Scholar
• Walch A, Meshkat M, Vogelsang H, et al. Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurines. J Crohns Colitis 2010;4:398-404
   PubMed Web of Science ®Google Scholar
• Cacheux W, Seksik P, Lemann M, et al. Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis. Am J Gastroenterol 2008;103:637-42
   PubMed Web of Science ®Google Scholar
• Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporin in ulcerative colitis: a five-year experience. Am J Gastroenterol 1999;94:1587-92
   PubMed Web of Science ®Google Scholar
• Molnar T, Farkas K, Szepes Z, et al. Long term outcome of cyclosporine rescue therapy in acute, steroid-refractory severe ulcerative colitis. United Eur Gastroenterol J 2014. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Actis GC, Fadda M, David E, et al. Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study. BMC Gastroenterol 2007;7:13
   PubMed Web of Science ®Google Scholar
• Fellermann K, Tanka Z, Herrlinger KR, et al. Response of refractory colitis to intravenous or oral tacrolimus (FK506). Inflamm Bowel Dis 2002;8:317-24
   PubMed Web of Science ®Google Scholar
• Hogenauer C, Wenzl HH, Hinterleitner TA, Petritsch W. Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis. Aliment Pharmacol Ther 2003;18:415-23
   PubMed Web of Science ®Google Scholar
• Ogata H, Matsui T, Nakamura M, et al. A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis. Gut 2006;55:1255-62
   PubMed Web of Science ®Google Scholar
• Baumgart DC, Pintoffl JP, Sturm A, et al. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease—a long-term follow-up. Am J Gastroenterol 2006;101:1048-56
   PubMed Web of Science ®Google Scholar
• Ogata H, Kato J, Hirai F, et al. Double-Blind, Placebo-Controlled Trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis. Inflamm Bowel Dis 2012;18:803-8
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Nakase H, Matsuura M, et al. Tacrolimus therapy as an alternative to thiopurines for maintaining remission in patients with refractory ulcerative colitis. J Clin Gastroenterol 2011;45:526-30
   PubMed Web of Science ®Google Scholar
• Gustavsson A, Jarnerot G, Hertervig E, et al. Clinical trial: colectomy after rescue therapy in ulcerative colitis – 3-year follow-up of the Swedish-Danish controlled infliximab study. Aliment Pharmacol Ther 2010;32:984-9
   PubMed Web of Science ®Google Scholar
• Kohn A, Daperno M, Armuzzi A, et al. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Aliment Pharmacol Ther 2007;26:747-56
   PubMed Web of Science ®Google Scholar
• Jakobovits SL, Jewell DP, Travis SP. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006. Aliment Pharmacol Ther 2007;25:1055-60
   PubMed Web of Science ®Google Scholar
• Annunziata ML, Hanauer SB. Calcineurin inhibition in severe ulcerative colitis: lost in translation? Inflamm Bowel Dis 2012;18:809-11
   PubMed Web of Science ®Google Scholar
• Laharie D, Bourreille A, Branche J, et al. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet 2012;380:1909-15
   PubMed Web of Science ®Google Scholar
• Dean KE, Hikaka J, Huakau JT, et al. Infliximab or cyclosporine for acute severe ulcerative colitis: a retrospective analysis. J Gastroenterol Hepatol 2012;27:487-92
   PubMed Web of Science ®Google Scholar
• Bossa F, Caruso N, Accadia L, et al. P127 - Oral cyclosporin vs infliximab in patients with severe ulcerative colitis refractory to iv steroids. Preliminary data of a controlled, randomized study. J Crohns Colitis 2009;3:61-70
   Google Scholar
• Croft A, Walsch A, Doecke J, et al. Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab. Aliment Phramacol Ther 2013;38:294-302
   PubMed Web of Science ®Google Scholar
• Chang KO, Burke JP, Coffey JC. Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis. Int J Colorectal Dis 2013;28:287-93
   PubMed Web of Science ®Google Scholar
• Comparison of infliximab and ciclosporin in steroid. resistant ulcerative colitis: a trial. Available from: http://www.controlled-trials.com/ISRCTN22663589
   Google Scholar
• Maser EA, Villela R, Silverberg MS, et al. Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn’s disease. Clin Gastroenterol Hepatol 2006;4:1248-54
   PubMed Web of Science ®Google Scholar
• Herrlinger KR, Barthel DN, Schmidt KJ, et al. Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus. Aliment Pharmacol Ther 2010;31:1036-41
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Nakase H, Matsuura M, et al. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus. J Gastroenterol Hepatol 2010;25:886-91
   PubMed Web of Science ®Google Scholar
• Maser EA, Deconda D, Lichtiger S, et al. Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis. Clin Gastroenterol Hepatol 2008;6:1112-16
   PubMed Web of Science ®Google Scholar
• Chaparro M, Burgueno P, Iglesias E, et al. Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study. Aliment Pharmacol Ther 2012;35:275-83
   PubMed Web of Science ®Google Scholar
• Leblanc S, Allez M, Seksik P, et al. Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis. Am J Gastroenterol 2011;106:771-7
   PubMed Web of Science ®Google Scholar
• Sternthal MB, Murphy SJ, George J, et al. Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease. Am J Gastroenterol 2008;103:937-43
   PubMed Web of Science ®Google Scholar
• Bálint A, Farkas K, Szücs M, et al. Long-term increase in serum cholesterol levels in ulcerative colitis patients treated with cyclosporine: an underdiagnosed side effect frequently associated with other drug-related complications. Scand J Gastroenterol 2014;49:59-65
   PubMed Web of Science ®Google Scholar
• Dayan B, Turner D. Role of surgery in severe ulcerative colitis in the era of medical rescue therapy. World J Gastroenterol 2012;18:3833-8
   PubMed Web of Science ®Google Scholar
• Kornbluth A. Cyclosporine versus infliximab for the treatment of severe ulcerative colitis. Gastroenterol Hepatol 2011;7:677-9
   Google Scholar
• Fabro M, Szabo H, Terrosu G, et al. Acute severe colitis: infliximab and/or Cyclosporine? Curr Drug Targets 2011;12:1448-53
   PubMed Web of Science ®Google Scholar
• Hart AL, Ng SC. Review article: the optimal medical management of acute severe ulcerative colitis. Aliment Pharmacol Ther 2010;32:615-27
   PubMed Web of Science ®Google Scholar